Cerahelix, with the slogan "The next generation in ceramic nanofiltration", is pioneering innovative ceramic membrane technology. Utilizing patented thin-film and DNA templating, Cerahelix has developed membranes that offer numerous advantages over existing technologies. These perks include lower operational costs, extended lifespan, heightened efficiency, minimal fouling, and no requirement for pre-treatment. As a result, the company's ceramic nanofiltration products boast lower CapEx, OpEx, and sustaining capital costs compared to competitors. Founded in 2011 and headquartered in the United States, Cerahelix secured a $3.00M Series B investment on 18 May 2020, with Rockies Venture Club as the investor. The company's applications span various industries, including biotechnology and manufacturing. Cerahelix's innovative approach to ceramic nanofiltration presents significant promise and potential for growth.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $3.00M | 1 | 18 May 2020 | |
Venture Round | $42.17K | 1 | 01 Jan 2020 | |
Seed Round | Unknown | 1 | 16 Apr 2018 | |
Series B | $2.00M | 3 | Propel(X) | 15 Mar 2018 |
Venture Round | $500.00K | - | 14 Jun 2017 |
No recent news or press coverage available for Cerahelix.